![Mark Eccleston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eccleston
Vorstandsvorsitzender bei
VALIRX PLC
Vermögen: 222 882 $ am 31.05.2026
Profil
Mark Edward Eccleston was the founder of Vivamer Ltd. (founded in 2002, title: Chief Scientific Officer) and Volition, Inc. (founded in 1997, title: Director-Business Development).
Current jobs include Chief Executive Officer & Director at ValiRx Plc (starting in 2024) and Managing Director & Director at Oncolytika Ltd. (starting in 2010).
Former jobs include Director at ADD Signs Ltd. (2010-2017) and Chief Technology Officer at VolitionRX Ltd. (2021-2024).
Education includes an MBA from the University Of Dundee (conferral date: 2008) and a doctorate from the University of Aston (conferral date: 1998).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VALIRX PLC 11.41% | 20.05.2026 | 84’746’187 ( 11.41% ) | 222 882 $ | 31.05.2026 |
Aktive Positionen von Mark Eccleston
| Unternehmen | Position | Beginn |
|---|---|---|
| VALIRX PLC | Vorstandsvorsitzender | 12.08.2024 |
Volition, Inc.
 Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Gründer | 14.03.1997 |
Oncolytika Ltd.
 Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Vorstandsvorsitzender | 01.06.2010 |
Ehemalige bekannte Positionen von Mark Eccleston
| Unternehmen | Position | Ende |
|---|---|---|
| VOLITIONRX LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
ADD Signs Ltd.
 ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Direktor/Vorstandsmitglied | 03.02.2017 |
Vivamer Ltd.
 Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Vorstandsvorsitzender | - |
Ausbildung von Mark Eccleston
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ValiRx Plc
 ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
Volition, Inc.
Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Technology Services |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivamer Ltd.
Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
ADD Signs Ltd.
ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Producer Manufacturing |
Oncolytika Ltd.
Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Commercial Services |
